Cargando…
Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells
Introduction: Doxorubicin (DOX), a chemotherapeutic drug, induces senescence and increases the secretion of senescence-associated secretory phenotype (SASP) in endothelial cells (ECs), which contributes to DOX-induced inflammaging. Metformin, an anti-diabetic drug, demonstrates senomorphic effects o...
Autores principales: | Abdelgawad, Ibrahim Y., Agostinucci, Kevin, Sadaf, Bushra, Grant, Marianne K. O., Zordoky, Beshay N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164964/ https://www.ncbi.nlm.nih.gov/pubmed/37168843 http://dx.doi.org/10.3389/fragi.2023.1170434 |
Ejemplares similares
-
EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2022) -
Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice
por: Agostinucci, Kevin, et al.
Publicado: (2023) -
Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation
por: Grant, Marianne K.O., et al.
Publicado: (2020) -
Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
por: Agostinucci, Kevin, et al.
Publicado: (2022) -
Doxorubicin Paradoxically Ameliorates Tumor-Induced Inflammation in Young Mice
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2021)